Navigation Links
Cisplatin-very Effective Than Carboplatin in Nonsmall Cell Lung Cancer Treatment

Some patients with advanced nonsmall-cell lung cancer (NSCLC) have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.

Most clinicians in North America prefer carboplatin to cisplatin because it has fewer side effects and is easier to administer. Andrea Ardizzoni, M.D., of University Hospital in Parma, Italy, and colleagues conducted a review of nine randomized trials comparing the survival of 2,968 NSCLC patients who received either cisplatin- or carboplatin-based chemotherapy.

Patients who received cisplatin lived slightly longer than those treated with carboplatin, with a median survival of 9.1 months compared with 8.4 months. The difference in survival was not statistically significant, because both drugs had side effect. Carboplatin was more likely to decrease blood platelet levels, while cisplatin was more likely to cause nausea, vomiting, and damage to the kidneys.

Christopher and colleagues discuss the renewed rivalry between cisplatin and carboplatin, particularly in the face of new developments in adjuvant chemotherapy for NSCLC patients. The apparent superiority of cisplatin over carboplatin demonstrated in this paper should not be taken lightly, particularly in patients being treated with curative intent.

Equally inadvisable would be the use of cisplatin in patients with metastatic NSCLC for whom the drug may be poorly tolerated, such as those with significant baseline renal impairment, hearing loss, peripheral neuropathy, or other serious medical comorbidities, the authors wrote.


'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... May 25, 2016 , ... A new update to ... to motion capture, all by utilizing a common Wi-Fi network and a mobile device. ... data from any location with Wi-Fi, and use a mobile device to control the ...
(Date:5/25/2016)... ... May 25, 2016 , ... The ... a $500,000 two-year pilot initiative to improve oral health-related awareness, education, prevention and ... for health care providers and promote best practices in 10 New Jersey counties ...
(Date:5/25/2016)... ... May 25, 2016 , ... Today American University ... College of Medicine announced the AUA-FIU Global MD Program. Students in the ... from AUA and a Certificate of Completion from the FIU Herbert Wertheim College ...
(Date:5/25/2016)... ... ... Today Omega Institute, a leading destination for yoga education in New York’s ... in the growing field of yoga therapy . Yoga therapy adapts the practice ... issues—including injuries, illnesses, and temporary or chronic health conditions. , “Yoga therapy is a ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today ... medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept for the ... numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot Group, which ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 2016 According to market research ... and Demand Forecast to 2022 - Industry Insights by ... published by P&S Market Research, the global insulin delivery ... and it is expected to grow at a CAGR ... pump segment is expected to witness the fastest growth ...
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
Breaking Medicine Technology: